TAG:
anatomic pathology services
CMS Anti-Markup Rules Target In-Office Ancillaries
By Robert Michel | From the Volume XV No. 10 – July 28, 2008 Issue
CEO SUMMARY: Medicare officials are again attempting to rein in what they consider to be potentially abusive forms of in-office ancillary services, including anatomic pathology. Proposed new rules published this month would clarify and perhaps expand the application of the Medicare anti-m…
CMS Expected to Revise Condo Lab & TC/PC Rules
By Robert Michel | From the Volume XV No. 8 – June 16, 2008 Issue
CEO SUMMARY: Expectations are that the Centers for Medicare & Medicaid Services (CMS) will take further action to rein in anatomic pathology arrangements used by physicians to capture revenue from their patient referrals. This may happen as soon as next month, when CMS publishes the 2…
Battles Continue Over Doctor Mark Up of Lab Tests
By R. Lewis Dark | From the Volume XV No. 6 – May 5, 2008 Issue
FROM THE SHADOWS OF A PARKING GARAGE, Deep Throat suggests to reporter Bob Woodward, “Follow the money.†In this scene from the movie, All the President’s Men, Woodward gets the right advice he needs from an unnamed source to pursue the Watergate case, a huge political scandal of the 1970s.  
Federal Judge to Look at CMS Rule-Making in Anti-Markup Case
By Robert Michel | From the Volume XV No. 5 – April 14, 2008 Issue
THERE’S BEEN WIDESPREAD INTEREST across the lab industry to news that on March 31, Uropath, LLC, won a preliminary injunction in its case to prevent the federal Centers for Medicare & Medicaid Services (CMS) from implementing an anti-markup regulation for patho…
Bostwick Labs Prepares For Public Stock Offering
By Robert Michel | From the Volume XV No. 4 – March 24, 2008 Issue
CEO SUMMARY: In recent years, annual revenue at Bostwick Laboratories has skyrocketed, reaching $102.8 mil- lion in 2007. Now the company, known for its national uropathology expertise, has filed documents in preparation for an initial public stock offering (IPO). Bostwick Laboratories is…
Mich. Dermatologist Gets 10.5 Years in Fraud Case
By Robert Michel | From the Volume XV No. 3 – March 3, 2008 Issue
CEO SUMMARY: In a federal case involving billing improprieties and insurance fraud, a federal judge sentenced Michigan dermatologist Robert W. Stokes, M.D., to 126 months in prison and ordered him to pay $178,100 in fines and assessments, with the amount of restitution yet to be determine…
Powerful Trends Reshaping Anatomic Path Profession
By Robert Michel | From the Volume XV No. 2 – February 11, 2008 Issue
CEO SUMMARY: THE DARK REPORT presents its newest biannual review of macro trends reshaping the anatomic pathology profession. These macro trends reveal a profession undergoing change and transformation on multiple fronts. New competitors are crowding into the market, payers and accreditin…
February 11, 2008 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XV No. 2 – February 11, 2008 Issue
In an attempt to stop or delay the start of the Medicare Laboratory Competitive Demonstration Project for the San Diego-Carlsbad-San Marcos SMA (statistical metropolitan area), a lawsuit has been filed in federal court by Internist Laboratory of Carlsbad, Sharp Healthcare …
CMS Spotlights AP as It Delays Anti-Markup Rule
By Robert Michel | From the Volume XV No. 1 – January 21, 2008 Issue
CEO SUMMARY: When Medicare officials postponed implementing a new anti-markup rule late last month, it did so because of questions about how the new rule will be applied. However, the Centers for Medicare & Medicaid Services (CMS) did implement an aspect of the anti-markup rule on Jan…
December 31, 2007 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XIV No. 18 – December 31, 2007 Issue
There’s late-breaking news affecting new federal rules for the anti-markup provisions scheduled to become effective on January 1, 2008. Just days ago, the federal Centers for Medicare & Medicaid Services…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized